APR 21, 2020 11:29 AM PDT

Researchers Develop COVID-19 Nasal Spray Vaccine

WRITTEN BY: Annie Lennon

Researchers from the University of Waterloo in Canada are working on a DNA-based vaccine for COVID-19 that can be applied using a nasal spray.

“When complete, our DNA-based vaccine will be administered non-invasively as a nasal spray that delivers nanomedicine engineered to immunize and decrease COVID-19 infections,” says Roderick Slavcev, a professor in the School of Pharmacy at the University of Waterloo. “This research combines the expertise of many and leverages existing technology developed by my team, which we’re reconfiguring for a COVID-19 application.” 

The vaccine will work via a process known as ‘engineered bacteriophage’, allowing the vaccine to trigger an immune response in the nasal cavity alongside targeted tissues such as the lungs in the lower respiratory tract. In this case, particles inside the vaccine will be able enter cells and produce virus-like particles (VLPs) that have a similar structure to SARS-CoV-2, the virus behind COVID-19. Unlike COVID-19 however, they will be harmless. 

After producing these SARS-CoV-2 look-alikes, the immune response will be activated to protect against them. It will also start to produce alternative structures that bind to the receptors that SARS-CoV-2 would otherwise bind to, thus limiting sites for possible transmission. 

In this way, the vaccine would both be able to help the body build immunity against COVID-19 and decrease the severity of infections as they progress. The researchers thus see that the approach may serve both as a vaccine and a therapeutic. 

This nasal vaccine is still some way from human trials however- let alone being available to the general public. This comes as the researchers are still modifying the design of the bacteriophage delivery system so that it may be applied to COVID-19. Further component design and testing of these are expected to happen later this year. 

Although perhaps a novel idea in vaccine development against COVID-19, nasal vaccines are not new. In fact, they are already used to immunize people against the flu. Arguably easier to deliver vaccines via nasal spray, researchers have noted that delivery by the nose may impede antigen absorption as mucus often prevents foreign substances, pathogens and particles from reaching the lungs and other tissue. Although not necessarily reflective of the potential for the new vaccine against COVID-19, research has shown that nasal vaccines tend to be less effective than injected vaccines in children. 


Sources: University of Waterloo, Global News, AAP


About the Author
  • Science writer with keen interests in technology and behavioral biology. Her current focus is on the interplay between these fields to create meaningful interactions, applications and environments.
You May Also Like
APR 07, 2020
APR 07, 2020
Second COVID-19 Vaccine Enters Human Trials
Yesterday, Inovio Pharmaceuticals, Inc. announced that it will begin human trials on a potential vaccine for COVID-19.
APR 15, 2020
APR 15, 2020
How Magic Mushrooms Restructure the Brain
For some time now, researchers have suspected that psilocybin, the hallucinogen chemical present in ‘magic mushroo ...
APR 20, 2020
Genetics & Genomics
APR 20, 2020
Advances in Gene Therapy for Neurons
New research may aid in the development of gene therapies for diseases like Alzheimer's and Parkinson's.
APR 23, 2020
Drug Discovery & Development
APR 23, 2020
Over 200 Volunteers Design $216 Ventilator for COVID-19
Over 200 volunteers from France have designed a ventilator suitable to treat COVID-19 patients that costs less than $500 ...
APR 28, 2020
APR 28, 2020
Is a multi-cancer detection blood test safe for women?
Earlier detection is essential in order to reduce deaths caused by cancer. A new study, DETECT-A (Detecting cancers Earl ...
MAY 07, 2020
MAY 07, 2020
New COVID-19 Vaccine Defends Monkeys Against Infection
Researchers from Beijing-based Sinovac Biotech have reported preliminary results of a study into the development of a va ...
Loading Comments...